Article
Novo investors seek clarity on Wegovy weight-loss drug shortages
Rating:
0.0
Views:
36
Likes:
1
Library:
1
When Novo Nordisk publishes third-quarter results next week investors and analysts are hoping the company will clarify when limits on the supply of starter doses of its weight-loss drug Wegovy in the United States will cease.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value